Helmholtz Zentrum München. (5/15/23). "Press Release: Responsible Use of Artificial Intelligence in Medicine. New Ad Hoc Working Group of BAdW in Cooperation With Helmholtz Munich Launched".

	Region	Bayern (federal state)
	Country	Germany
	Organisation	Helmholtz-Zentrum München – Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (HMGU)
	Group	Helmholtz-Gemeinschaft (HGF) (Group)
	Product	AI-based healthcare/medical product
	Product 2	medicine
	Person	Tschöp, Matthias H. (Helmholtz 202001 CEO at Helmholtz Zentrum München)

A new ad hoc working group with the topic of “artificial intelligence in medicine” started at the Bavarian Academy of Sciences and Humanities (BAdW). The project is planned for three years and will be executed by the Bavarian Academy of Sciences and Humanities together with Helmholtz Munich. The project brings together scientists from a variety of disciplines with a shared goal to analyze the chances and risks of artificial intelligence (AI) in medicine. As a central point of contact for policy makers, the new working group aims to proactively address emerging issues in the field of AI applications in medicine.

Building a Network of AI Activities in the Health Sector at Bavarian Research Institutions

Our everyday lives have fundamentally changed as a result of the rapid AI development with a particular impact of GhatGPT. Many excellent initiatives and research projects focusing on AI in medicine have already emerged in Bavaria. Markus Schwaiger, President of the Bavarian Academy of Sciences and Humanities, emphasizes: "It is important to now cross-link AI activities in the health sector at Bavarian research institutions in order to accelerate the development and use of AI methods benefiting patients and to strengthen Bavaria as a science location in the national and international competition."

Today AI Is Essential in Cutting-Edge Medical Research

AI applications are becoming increasingly powerful, and their range of application enlarges steadily. In medicine in particular, AI-supported methods are opening up groundbreaking opportunities to improve diagnostic and treatment procedures, develop new therapeutic approaches quicker, and thus significantly increase people's quality of life and life expectancy. Physician and Scientific Director of Helmholtz Munich, Matthias H. Tschöp, explains: “Today, AI is essential in cutting-edge medical research opening up new possibilities, especially when it comes to disease prevention, which involves effective analysis of large amounts of data. Thereby leading us away from repair medicine and towards personalized prevention.” The fact that the future with AI must be actively shaped is also reflected in the draft of the deputies at the European Parliament who are currently launching the Artificial Intelligence Act providing for the first-time regulations for artificial intelligence systems and applications in the European Union.

Keeping this in mind, the new working group will promote open, ethical-legal discussions about the benefits and opportunities of personalized medicine. The working group supplies support to actively shape the future of AI applications in medicine and ensures responsible usage for the benefit of all.

Ad Hoc Working Groups of BAdW

The ad hoc working groups of the Bavarian Academy of Sciences and Humanities are dedicated to innovative research ideas or questions of high social and political relevance with a duration of three years. The working groups "Islam in Bavaria" and "Facticity of the World", among others, have already been completed. Currently running are the working groups "AI in Medicine" and "Judaism in Bavaria in History and Present".

Record changed: 2024-01-20